Vektor Medical, Inc.

Attending SCRN in Lisbon? Check out Dr. D'Souza's presentation on Tuesday reviewing the benefits of non-invasive mapping using AI. #SCRN #vMap #AI #cardiology #epeeps

An AI solution exists today that will help reduce the global burden of cardiac arrhythmia. “𝙄𝙩’𝙨 𝙚𝙭𝙩𝙧𝙚𝙢𝙚𝙡𝙮 𝙙𝙞𝙛𝙛𝙞𝙘𝙪𝙡𝙩 𝙩𝙤 𝙪𝙣𝙙𝙚𝙧𝙨𝙩𝙖𝙣𝙙 𝙖 𝙘𝙖𝙧𝙙𝙞𝙖𝙘 𝙖𝙧𝙧𝙝𝙮𝙩𝙝𝙢𝙞𝙖 𝙖𝙣𝙙 𝙩𝙝𝙚 𝙥𝙧𝙚𝙘𝙞𝙨𝙚 𝙡𝙤𝙘𝙖𝙩𝙞𝙤𝙣 𝙤𝙛 𝙞𝙩𝙨 𝙨𝙤𝙪𝙧𝙘𝙚, 𝙬𝙝𝙚𝙩𝙝𝙚𝙧 𝙛𝙧𝙤𝙢 𝙖𝙣 𝙀𝘾𝙂 𝙤𝙧 𝙖𝙣𝙮 𝙤𝙛 𝙩𝙝𝙚 𝙘𝙤𝙢𝙢𝙤𝙣𝙡𝙮 𝙪𝙨𝙚𝙙 𝙩𝙤𝙤𝙡𝙨 𝙞𝙣 𝙘𝙖𝙧𝙙𝙞𝙤𝙡𝙤𝙜𝙮. 𝙃𝙤𝙬𝙚𝙫𝙚𝙧, 𝙬𝙞𝙩𝙝 𝙟𝙪𝙨𝙩 𝙩𝙝𝙚 𝙥𝙖𝙩𝙞𝙚𝙣𝙩’𝙨 𝙀𝘾𝙂 𝙖𝙣𝙙 𝙤𝙪𝙧 𝙖𝙧𝙩𝙞𝙛𝙞𝙘𝙞𝙖𝙡 𝙞𝙣𝙩𝙚𝙡𝙡𝙞𝙜𝙚𝙣𝙘𝙚 𝙨𝙤𝙡𝙪𝙩𝙞𝙤𝙣, 𝙬𝙝𝙞𝙘𝙝 𝙬𝙚 𝙘𝙖𝙡𝙡 𝙫𝙈𝙖𝙥, 𝙬𝙚’𝙧𝙚 𝙖𝙗𝙡𝙚 𝙩𝙤 𝙨𝙪𝙘𝙘𝙚𝙨𝙨𝙛𝙪𝙡𝙡𝙮 𝙖𝙣𝙙 𝙣𝙤𝙣-𝙞𝙣𝙫𝙖𝙨𝙞𝙫𝙚𝙡𝙮 𝙪𝙣𝙙𝙚𝙧𝙨𝙩𝙖𝙣𝙙 𝙩𝙝𝙚 𝙤𝙧𝙞𝙜𝙞𝙣𝙨 𝙤𝙛 𝙖 𝙥𝙖𝙩𝙞𝙚𝙣𝙩’𝙨 𝙖𝙧𝙧𝙝𝙮𝙩𝙝𝙢𝙞𝙖." Hear more from our CEO Robert J. Krummen's presentation at #LSIEurope. ⬇️ #medtech #cardiology #innovation #ai

Simple name. Game-changing analysis. vMap is an AI-based technology that compares ECG data and specific patient disease characteristic information with an extensive database of arrhythmia simulations to noninvasively locate arrhythmia source locations. #medtech #healthcareinnovation #cardiology

🫀"You can plan for a procedure better. The procedure then is not empirical; you are making it individualized."🫀 In today's 𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝗜𝗻𝘀𝗶𝗴𝗵𝘁 segment, Dr. Jag Singh discusses how EPs can use AI-based strategies and tools to improve workflow and outcomes. #cardiology #ai #innovation #medtech

🫀Data shows the use of vMap during complex AF ablation procedures can significantly improve freedom from atrial arrhythmias compared with standard-of-care pulmonary vein isolation. ⬇️ A recent study found that additional AF driver site ablation guided by vMap was associated with an 86.5% freedom from all atrial arrhythmias compared to 48.0% of the control group. Presented at AF Symposium, "Ablation of Non-Pulmonary Vein Atrial Fibrillation Drivers Identified by vMap in Addition to Pulmonary Vein Isolation Improves Procedural Outcomes." Details available here: https://lnkd.in/gN8Z8Mdx #cardiology #clinicaldata #medtech

“We wanted to be able to leverage both the expertise we had in the United States and the expertise that existed in Europe. It was a match made in heaven.” Vektor Medical CEO Robert J. Krummen shared his insights on the importance of building cross-border relationships for investors and innovators alike as part of a recent panel discussion at LSI Europe ’24. You can view the entire discussion, “Building Syndicates of Cross-Border Investors in Medtech Companies,” and hear more from Rob and other panelists below: Ashley Seehusen (Moderator), Venture Partner SANTÉ Ventures & CEO at Santé Accel C David Adair MD, MBA, FACOG, FASH, C-EFM, Managing Partner & Co-Founder, Solas BioVentures Dr. Luc Marengere, Managing Partner, TVM Capital Life Science Alexander Goemans, CFO, Xeltis #medtech #lsieurope24 #innovation #lsialumni

🫀Clinical Case with Dr. Gordon Ho, UCSD: Male patient, 70-79 years old, with EF at 40%, presented for VT ablation. Since July, the patient has had 7 VT events with subsequent ICD shocks. 🔎 While the patient was on the monitor prior to the case starting, he had occasional PVCs that were similar in morphology to the clinical VT. This was mapped in vMap which localized a hotspot in the LVOT inferior to the LCC near the LV summit. The LV was accessed via the retrograde aortic approach. Pacing procedures produced a short run of VT that matched the clinical and PVC morphology; however, it was non-sustained. This ECG was mapped in vMap and localized a hotspot in the LVOT, in the commissure between the LCC and RCC. The patient was then paced into a sustained VT and remained hemodynamically stable. 🎯 Dr. Ho then began to ablate in this commissure area, where the VT eventually terminated and was unable to be induced again after pacing. #epeeps #cardiology #EPLab #clinicalexperience #VT

The Vektor team is headed to Brooklyn this week for VT Symposium! Stop by our booth in the Grand Ballroom to experience vMap and learn how our noninvasive, AI-based arrhythmia analysis and localization tool can improve, enhance, and accelerate VT ablation procedures. Send us a message or reach out here to schedule a meeting: https://lnkd.in/gWmxKSrm #VTSymposium #epeeps #medtech

Utilizing advanced algorithms and AI-based techniques, vMap enables physicians to rapidly and accurately locate source locations for both focal and fibrillation-type arrhythmias, driving enhanced outcomes and efficiencies. Learn more: https://lnkd.in/giR2j-M7 #cardiology #medtech #healthcare #innovation

vMap is an AI-based, FDA-cleared system for improving cardiac ablation outcomes and procedural efficiency. https://lnkd.in/gBKVD5w6 #medtech #disruptivetechnology #cardiology